Cargando…

Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report

BACKGROUND: Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant tumor susceptibility syndrome, and the disease-related gene has been identified as fumarate hydratase (fumarase, FH). HLRCC-associated kidney cancer is an aggressive tumor characterized by early metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamai, Takao, Abe, Hideyuki, Arai, Kyoko, Murakami, Satoshi, Sakamoto, Setsu, Kaji, Yasushi, Yoshida, Ken-Ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794818/ https://www.ncbi.nlm.nih.gov/pubmed/26983443 http://dx.doi.org/10.1186/s12885-016-2272-7

Ejemplares similares

Protein Profiling of Blood Samples from Patients with Hereditary Leiomyomatosis and Renal Cell Cancer by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
por: Kamai, Takao, et al.
Publicado: (2012)

A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
por: Yonese, Ichiro, et al.
Publicado: (2020)

Single minimum incision endoscopic radical nephrectomy for renal tumors with preoperative virtual navigation using 3D-CT volume-rendering
por: Kamai, Takao, et al.
Publicado: (2010)

Hereditary leiomyomatosis and renal cell carcinoma
por: Schmidt, Laura S, et al.
Publicado: (2014)

Hereditary Leiomyomatosis and Renal Cell Cancer
por: HANSEN, Anders Würgler, et al.
Publicado: (2020)

Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma
por: Kamai, Takao, et al.
Publicado: (2009)

A Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma
por: Mehrtens, Sarah, et al.
Publicado: (2016)

Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma
por: Nukui, Akinori, et al.
Publicado: (2017)

Clinically significant association between the maximum standardized uptake value on (18)F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer
por: Mizuno, Tomoya, et al.
Publicado: (2015)

Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis
por: Kamai, Takao, et al.
Publicado: (2007)

A Non-Hereditary Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
por: Kapila, Vaishali, et al.
Publicado: (2021)

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy
por: Nukui, Akinori, et al.
Publicado: (2017)

Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma
por: Kamai, Takao, et al.
Publicado: (2021)

Abnormal 18F-FDG uptakes in the prostate due to two different conditions of urine reflux: a mimicker of prostate cancer
por: Inamura, Kensuke, et al.
Publicado: (2016)

Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids
por: Bortoletto, Pietro, et al.
Publicado: (2017)

Hereditary leiomyomatosis and renal cell carcinoma: Case report and review of the literature
por: Natália, Ferreira, et al.
Publicado: (2018)

Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
por: Chaucer, Benjamin, et al.
Publicado: (2018)

Hereditary leiomyomatosis and renal cell cancer (HLRCC): A case report
por: Yonamine, Tomoko, et al.
Publicado: (2020)

Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis
por: Yuki, Hideo, et al.
Publicado: (2018)

Higher preoperative serum levels of PD‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF‐targeted therapy and unfavorable prognosis of renal cell carcinoma
por: Fukuda, Takehiko, et al.
Publicado: (2016)

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival
por: Kamai, Takao, et al.
Publicado: (2021)

Hereditary Leiomyomatosis and Renal Cell Cancer: A Case Report of Pilar Leiomyomatosis with History of Kidney Cancer and Review of the Literature
por: Kim, Jee-Woo, et al.
Publicado: (2023)

Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization
por: Sánchez-Heras, A. Beatriz, et al.
Publicado: (2020)

Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review
por: Chayed, Zahraa, et al.
Publicado: (2021)

Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment
por: Zhang, Congwang, et al.
Publicado: (2021)

Hereditary leiomyomatosis and renal cell cancer syndrome – case report and review of the literature
por: Popa, Liliana Gabriela, et al.
Publicado: (2020)

Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives
por: Catarina, Tavares, et al.
Publicado: (2022)

Hereditary Leiomyomatosis and Renal Cell Carcinoma: A Case Report and Review of the Literature
por: Alrawaf, Faisal A, et al.
Publicado: (2022)

Dermatologists might be the first to suspect hereditary leiomyomatosis and renal cell carcinoma syndrome()
por: González-Guerra, Elena, et al.
Publicado: (2023)

Circulating tumor cells and cell-free tumor DNA analyses in urothelial cancer using the LiquidBiopsy platform
por: Kobayashi, Minoru, et al.
Publicado: (2022)

A novel pathogenic variant of the FH gene in a family with hereditary leiomyomatosis and renal cell carcinoma
por: Yagi, Yasuto, et al.
Publicado: (2022)

Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer
por: Yamaguchi, Yoshiyuki, et al.
Publicado: (2019)

Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer
por: Nukui, Akinori, et al.
Publicado: (2018)

Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients
por: Seo, Ja Young, et al.
Publicado: (2021)

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
por: Bateman, Nicholas W., et al.
Publicado: (2021)

A sheep in wolf's clothing; a case of renal leiomyoma masquerading as hereditary leiomyomatosis and renal cell carcinoma
por: Uzzo, Nicole, et al.
Publicado: (2023)

Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes
por: Al-Shinnag, Mohammad, et al.
Publicado: (2021)

Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma
por: Masuda, Akinori, et al.
Publicado: (2014)

Post-transplant diagnosis of hereditary leiomyomatosis and renal cell carcinoma syndrome in a kidney donor
por: Lee, Jonathan J., et al.
Publicado: (2014)

Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report and implications of early onset
por: Çaliskan, Ercan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aj2aq3fo5f95ro4bl3bbr8eii5